In this article, we will explore the topic of Oxabolone cipionate in depth. From its origins to its relevance today, we will put under the magnifying glass all aspects related to Oxabolone cipionate. Our goal is to offer our readers a complete and detailed view of this topic, providing invaluable information that allows them to better understand its importance and impact in various areas. Through an exhaustive analysis and the presentation of relevant data, we are going to delve into Oxabolone cipionate to unravel its implications and its scope in different contexts. Without a doubt, Oxabolone cipionate is a highly relevant topic that deserves careful examination, and that is precisely what we will do in the following pages. So get ready to embark on a fascinating journey through Oxabolone cipionate.
| Clinical data | |
|---|---|
| Trade names | Steranabol Depo, Steranabol Ritardo |
| Other names | Oxabolone cypionate; FI-5852; 4-Hydroxy-19-nortestosterone 17β-cypionate; Estr-4-en-4,17β-diol-3-one 17β-cypionate |
| Routes of administration | Intramuscular injection[1] |
| Drug class | Androgen; Anabolic steroid; Androgen ester |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.013.647 |
| Chemical and physical data | |
| Formula | C26H38O4 |
| Molar mass | 414.586 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Oxabolone cipionate (INN, JAN) (brand names Steranabol Depo, Steranabol Ritardo; former developmental code name FI-5852), or oxabolone cypionate, also known as 4-hydroxy-19-nortestosterone 17β-cypionate or estr-4-en-4,17β-diol-3-one 17β-cypionate, is synthetic and injected anabolic–androgenic steroid (AAS) and derivative of nandrolone (19-nortestosterone) which has been marketed in Europe.[1][2][3] It is the C17β cypionate ester and a prodrug of oxabolone (4-hydroxy-19-nortestosterone).[2][3]